Klinge Pharma GmbH
Records under this name other than patents Klinge Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,077,534 | Production of pharmaceutical formulations for treatment of edema and venous disorders Formerly held Term ended Term ended Sep 2, 2017 · From the USPTO record | Term ended | Term ended Sep 2, 2017 | From the USPTO record |
| US 7,320,993 | Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents Formerly held Lapsed on the fee record Ended Jan 22, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2016 | From the USPTO record |
| US 7,276,524 | Pyridyl alkane acid amides as cytostatics and immunosuppressives Formerly held Lapsed on the fee record Ended Oct 2, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 2, 2015 | From the USPTO record |
| US 6,593,344 | Piperadinyl-substituted pyridylalkane, alkene and alkine carboxamides Formerly held Lapsed on the fee record Ended Jul 15, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 15, 2015 | From the USPTO record |
| US 7,241,745 | Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives Formerly held Lapsed on the fee record Ended Jul 10, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 10, 2015 | From the USPTO record |
| US 7,192,967 | Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents Formerly held Lapsed on the fee record Ended Mar 20, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 20, 2015 | From the USPTO record |
| US 6,506,572 | Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy Formerly held Lapsed on the fee record Ended Jan 14, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2015 | From the USPTO record |
| US 6,451,816 | Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression Formerly held Lapsed on the fee record Ended Sep 17, 2014 · From the USPTO record | Lapsed on the fee record | Ended Sep 17, 2014 | From the USPTO record |
| US 6,444,823 | Pyridyl alkane acid amides as cytostatics and immunosuppressives Formerly held Lapsed on the fee record Ended Sep 3, 2014 · From the USPTO record | Lapsed on the fee record | Ended Sep 3, 2014 | From the USPTO record |
| US 6,419,959 | Galenic composition containing opioid antagonists Formerly held Lapsed on the fee record Ended Jul 16, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2014 | From the USPTO record |